{"meta":{"query_hash":"7c8496ef025a","filters":{"venue":"International Journal of Clinical Pharmacology and Therapeutics"},"cohort_total":25,"direct_labels_cover":1,"predictions_cover":25,"exported":25,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/7c8496ef025a","api":"https://metacan.xera.ac/api/v1/cohort?venue=International+Journal+of+Clinical+Pharmacology+and+Therapeutics"},"results":[{"id":"W1159898105","doi":"10.5414/cp202429","title":"Potentially inappropriate medication use at ambulatory care visits by elderly patients covered by National Health Insurance in Korea","year":2015,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical prescription; Ambulatory; Ambulatory care; Health care; Public health; National health insurance; Emergency medicine; Family medicine; Medical emergency; Environmental health; Population; Internal medicine; Nursing","score_opus":0.1585787958774686,"score_gpt":0.4953132169656999,"score_spread":0.3367344210882313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1159898105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99891067,0.00040195326,0.000028509317,0.0000662749,0.0000030295134,0.000008497867,0.00029455355,0.0000016216143,0.00028493867],"genre_scores_gemma":[0.99943393,0.00021926618,0.0000635549,0.000043493295,0.000003565982,0.000004760521,0.00018802988,4.4785548e-7,0.000042867698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99945945,0.00014192898,0.00015364047,0.00007623175,0.00009745784,0.00007127496],"domain_scores_gemma":[0.9985461,0.0001320315,0.0010239313,0.00003257473,0.00012746069,0.00013787822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045862058,0.00015125639,0.00022820427,0.0007613403,0.00026255054,0.00038033657,0.00016445621,0.0002074026,0.00072107714],"category_scores_gemma":[0.0015409763,0.00014432067,0.00039170444,0.0009457574,0.00010987846,0.00033327844,0.00037581904,0.00025743636,0.00007973822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021311067,0.00001998981,0.9978411,0.000020386055,0.000025995085,0.00008018489,0.000071463954,0.000010838068,0.000075802716,0.00000719063,0.00008607465,0.0017395496],"study_design_scores_gemma":[0.0000027594551,0.000030493786,0.9991314,0.000016554159,0.000022106915,0.00027136158,0.00024426467,0.00009810217,0.00003235523,0.0000068693935,0.00014122375,0.0000025919912],"about_ca_topic_score_codex":0.007850806,"about_ca_topic_score_gemma":0.015433216,"teacher_disagreement_score":0.007850806,"about_ca_system_score_codex":0.00031592476,"about_ca_system_score_gemma":0.00047413015,"threshold_uncertainty_score":0.015610218},"labels":[],"label_agreement":null},{"id":"W1524993883","doi":"10.5414/cpp46072","title":"STOPP (Screening Tool of Older Persons Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation","year":2008,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1487,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"","keywords":"Medicine; Medical prescription; Context (archaeology); Delphi method; Cohen's kappa; Adverse effect; Family medicine; Geriatrics; Older people; MEDLINE; Gerontology; Psychiatry; Nursing","score_opus":0.26845476337603874,"score_gpt":0.49605273914793574,"score_spread":0.227597975771897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1524993883","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69915473,0.0016954989,0.113583,0.004133471,0.00072460395,0.11690969,0.017418562,0.0009902952,0.045390137],"genre_scores_gemma":[0.64434505,0.00081674865,0.22439665,0.0011770775,0.000109039494,0.11448274,0.009308799,0.00011461335,0.0052492092],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.93219113,0.03957701,0.011650543,0.00220925,0.012908865,0.0014632397],"domain_scores_gemma":[0.86969864,0.070913106,0.014807832,0.0041288286,0.037513316,0.002938228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.06666997,0.00069311087,0.0009944399,0.0056509147,0.00081220793,0.0010859873,0.0012552823,0.00126319,0.004597882],"category_scores_gemma":[0.1126124,0.00056874607,0.002467916,0.00272508,0.0012183505,0.00187367,0.0041723163,0.0010459024,0.0011252858],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003685584,0.0019640706,0.29676577,0.014822785,0.00090675516,0.0014233823,0.03206532,0.006219195,0.0072160023,0.007962805,0.046767298,0.5802011],"study_design_scores_gemma":[0.0031402553,0.0058457,0.81841356,0.008588055,0.0009219531,0.0028170496,0.025399957,0.025694404,0.009631263,0.010218038,0.08880205,0.0005277937],"about_ca_topic_score_codex":0.0021956216,"about_ca_topic_score_gemma":0.0039318744,"teacher_disagreement_score":0.06666997,"about_ca_system_score_codex":0.002320719,"about_ca_system_score_gemma":0.01062816,"threshold_uncertainty_score":0.3525887},"labels":[],"label_agreement":null},{"id":"W1979626182","doi":"10.5414/cpp46055","title":"Rapidly dissolving formulations for quick absorption during pain episodes: Ibuprofen","year":2008,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ibuprofen; Bioavailability; Pharmacokinetics; Absorption (acoustics); Anesthesia; Chemistry; Medicine; Bolus (digestion); Dissolution; Pharmacology; Internal medicine; Materials science","score_opus":0.09540455734546784,"score_gpt":0.454859478755467,"score_spread":0.3594549214099992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979626182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914511,0.0046738996,0.002240659,0.00008839777,0.000040186726,0.00014922554,0.00012436707,0.000071842485,0.00116035],"genre_scores_gemma":[0.9860225,0.0032621776,0.008065378,0.00007589786,0.000048718906,0.00012832847,0.0003085329,0.000022453942,0.0020660602],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99986696,0.00002424422,0.000012208397,0.000020557249,0.000048297632,0.000027794067],"domain_scores_gemma":[0.99984396,0.000026039485,0.00007317588,0.000011554291,0.000017528595,0.000027669868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021780116,0.0005043379,0.00045761943,0.00033703377,0.00013719036,0.00022152133,0.00019180255,0.00034901593,0.0024468552],"category_scores_gemma":[0.00026142725,0.00016389234,0.00028571425,0.00013347625,0.00016168188,0.00031921882,0.00015657887,0.0005875744,0.00042486476],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020874122,0.00059742655,0.00025039975,0.00014706717,0.000018264243,0.000082486426,0.000022983113,0.000061639184,0.981741,0.000052360458,0.00008929913,0.014849611],"study_design_scores_gemma":[0.00094212446,0.05507618,0.013546694,0.00006185889,0.00014249753,0.0016616578,0.0000528689,0.0011722947,0.9219781,0.0000622376,0.0052822917,0.00002116821],"about_ca_topic_score_codex":0.00026967246,"about_ca_topic_score_gemma":0.00046956807,"teacher_disagreement_score":0.0024468552,"about_ca_system_score_codex":0.00011445227,"about_ca_system_score_gemma":0.00017898648,"threshold_uncertainty_score":0.0081855655},"labels":[],"label_agreement":null},{"id":"W1980977108","doi":"10.5414/cpp45155","title":"Intraoperative small-dose ketamine does not reduce pain or analgesic consumption during perioperative opioid analgesia in children after tonsillectomy","year":2007,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Remifentanil; Ketamine; Anesthesia; Pacu; Analgesic; Perioperative; Tonsillectomy; Visual analogue scale; Morphine; Opioid; Placebo; Sufentanil; Surgery; Propofol; Internal medicine","score_opus":0.057299391974508056,"score_gpt":0.4262603040682083,"score_spread":0.36896091209370024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980977108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983182,0.001334511,0.00012333144,0.000035415105,0.0000127068915,0.000027046215,0.000028050248,0.0000050039393,0.00011585033],"genre_scores_gemma":[0.9985098,0.00082014897,0.00044440906,0.000039016002,0.000024642874,0.000043382483,0.00005313042,0.0000026930645,0.000062704334],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99956685,0.0001583969,0.00006064286,0.000053341646,0.000111496534,0.000049182825],"domain_scores_gemma":[0.99861467,0.00036904894,0.0007383971,0.00006640949,0.000047763173,0.00016368336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005432566,0.00026602097,0.0007814581,0.00009502702,0.00011368673,0.00024118494,0.00022654925,0.0002456169,0.00079279323],"category_scores_gemma":[0.0023729166,0.00014065999,0.00028700562,0.00014574232,0.00049655134,0.0003809484,0.00015346505,0.0004593254,0.00009169952],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25094992,0.009576492,0.2201155,0.0034971708,0.0015155586,0.0011986248,0.00078077306,0.0008655394,0.2510327,0.0002120771,0.0008837191,0.25937194],"study_design_scores_gemma":[0.015349621,0.3322052,0.6019208,0.00022244925,0.0011498764,0.0033750525,0.0005643009,0.0008348779,0.041156486,0.00009169725,0.0030939989,0.00003570066],"about_ca_topic_score_codex":0.00026542915,"about_ca_topic_score_gemma":0.0006483096,"teacher_disagreement_score":0.00079279323,"about_ca_system_score_codex":0.00018030233,"about_ca_system_score_gemma":0.0003774772,"threshold_uncertainty_score":0.0028730035},"labels":[],"label_agreement":null},{"id":"W1987788334","doi":"10.5414/cpp44284","title":"Bioequivalence of abacavir generic and innovator formulations under fasting and fed conditions","year":2006,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Abacavir; Bioequivalence; Cmax; Innovator; Pharmacokinetics; Pharmacology; Bioavailability; Area under the curve; Chemistry; Chromatography; Mathematics; Medicine; Human immunodeficiency virus (HIV); Viral load","score_opus":0.08713436940041538,"score_gpt":0.454361885679592,"score_spread":0.3672275162791766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987788334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981964,0.00045689466,0.00053776725,0.000021306685,0.000023585295,0.00017374718,0.00017364198,0.000017575745,0.00039901526],"genre_scores_gemma":[0.9968292,0.00026189387,0.0016597379,0.00006537476,0.000029880153,0.00027412447,0.00028755105,0.000009525511,0.00058280263],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9981134,0.0010093071,0.00012236743,0.00034473644,0.00031570854,0.000094608564],"domain_scores_gemma":[0.9992724,0.0001854037,0.000274443,0.00010306662,0.00008629197,0.000078387864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021930835,0.00037588784,0.00092884,0.0002517123,0.0002002201,0.00042266582,0.00031834352,0.0005440686,0.0022324985],"category_scores_gemma":[0.0023686455,0.00030172756,0.0003543316,0.00025585174,0.0005903901,0.00057831494,0.00020968587,0.0005452634,0.00026616507],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.43557084,0.009338652,0.011943335,0.0006745773,0.00085109833,0.00012402056,0.0008616816,0.00148668,0.43281266,0.0005326903,0.00083649927,0.1049673],"study_design_scores_gemma":[0.039774515,0.66171014,0.14672837,0.000118859854,0.0013602668,0.0009533446,0.00039945898,0.007037542,0.13304138,0.0004876804,0.008230117,0.00015829923],"about_ca_topic_score_codex":0.00046529603,"about_ca_topic_score_gemma":0.00030882025,"teacher_disagreement_score":0.0022324985,"about_ca_system_score_codex":0.00032113577,"about_ca_system_score_gemma":0.00026767058,"threshold_uncertainty_score":0.011598229},"labels":[],"label_agreement":null},{"id":"W1988275370","doi":"10.5414/cpp47358","title":"Bioequivalence study of a film-coated tablet of deferiprone in healthy Thai volunteers","year":2009,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bioequivalence; Pharmacokinetics; Deferiprone; Medicine; Cmax; Crossover study; Bioavailability; Area under the curve; Pharmacology; High-performance liquid chromatography; Placebo; Chromatography; Internal medicine; Thalassemia; Chemistry","score_opus":0.1672128938931037,"score_gpt":0.5375465013467459,"score_spread":0.3703336074536422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988275370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981318,0.0008324814,0.00041817423,0.000029465855,0.00003081382,0.00020047845,0.00010249129,0.000017424525,0.00023690742],"genre_scores_gemma":[0.9976539,0.0003618951,0.0009857839,0.00007083328,0.000037213773,0.00017732158,0.00017129538,0.00000587936,0.00053588575],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99927694,0.00032187047,0.000047294863,0.00017008584,0.00015162642,0.000032219275],"domain_scores_gemma":[0.99945086,0.00015570155,0.00014936602,0.000056969526,0.00007817861,0.00010884688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010078197,0.00051439,0.0009992893,0.00017342305,0.00022293207,0.00039967347,0.0002734131,0.0007167305,0.0015795797],"category_scores_gemma":[0.0016235001,0.0002473432,0.00031624237,0.00017822134,0.00047977534,0.0004076116,0.00016324242,0.0004866609,0.00030431256],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50661576,0.019069118,0.012868929,0.0020705194,0.0010374271,0.00049727876,0.0017800537,0.001062075,0.363468,0.00027312315,0.0009762391,0.09028144],"study_design_scores_gemma":[0.05407774,0.7857421,0.10704279,0.00008733201,0.0011784853,0.0015431732,0.00064621755,0.0049919584,0.04056205,0.00014476036,0.0038774237,0.00010609859],"about_ca_topic_score_codex":0.00054569985,"about_ca_topic_score_gemma":0.00038933763,"teacher_disagreement_score":0.0015795797,"about_ca_system_score_codex":0.00019111998,"about_ca_system_score_gemma":0.00021658784,"threshold_uncertainty_score":0.0053299665},"labels":[],"label_agreement":null},{"id":"W1992917631","doi":"10.5414/cp201845","title":"Approvable generic carbamazepine formulations may not be bioequivalent in target patient populations","year":2013,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Pharmacokinetics; Cmax; Pharmacology; Carbamazepine; Medicine; Population","score_opus":0.3202860587396284,"score_gpt":0.5351534356356845,"score_spread":0.21486737689605612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992917631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9466729,0.002674649,0.038644493,0.0011206153,0.000103567494,0.0004997989,0.0007274333,0.00030829737,0.009248291],"genre_scores_gemma":[0.99236333,0.00037883464,0.005837598,0.0005390229,0.00003393998,0.0001407212,0.00035373593,0.00003294417,0.00031988297],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9945979,0.0031417818,0.00037763437,0.0005853134,0.0011753357,0.00012199647],"domain_scores_gemma":[0.99333835,0.0042541246,0.0012543716,0.00072165206,0.00036205535,0.00006945817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007246558,0.00027841533,0.0009207236,0.0002497611,0.00022076143,0.0013592811,0.00050864235,0.0009862046,0.003380426],"category_scores_gemma":[0.022769356,0.00019851972,0.00066901755,0.00027687367,0.00048943073,0.0006964314,0.00035097805,0.00081939,0.00068341865],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031758424,0.0023017537,0.12882966,0.0026420765,0.004350231,0.0020380004,0.0015077358,0.025253156,0.14167455,0.023638941,0.0060025197,0.63000286],"study_design_scores_gemma":[0.013668002,0.09584614,0.38964486,0.0007906073,0.007251537,0.02262496,0.00160135,0.14461716,0.17445616,0.07739925,0.07181601,0.0002840038],"about_ca_topic_score_codex":0.00020089898,"about_ca_topic_score_gemma":0.00013740914,"teacher_disagreement_score":0.007246558,"about_ca_system_score_codex":0.00036507318,"about_ca_system_score_gemma":0.00049878046,"threshold_uncertainty_score":0.03832388},"labels":[],"label_agreement":null},{"id":"W1995951077","doi":"10.5414/cpp46319","title":"Pharmacodynamic equivalence of two orlistat capsule formulations in healthy volunteers under fed conditions","year":2008,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; BioPhage Pharma (Canada)","funders":"","keywords":"Orlistat; Feces; Pharmacodynamics; Pharmacokinetics; Excretion; Medicine; Meal; Capsule; Obesity; Animal science; Internal medicine; Biology; Weight loss","score_opus":0.12182689758838558,"score_gpt":0.5175710172026533,"score_spread":0.3957441196142677,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995951077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974027,0.00075479306,0.00049242843,0.00003986824,0.00005917005,0.0004402751,0.00034138924,0.000026398333,0.00044293396],"genre_scores_gemma":[0.9958183,0.0005550812,0.0011478529,0.00019792406,0.00009633215,0.00056457357,0.0007593619,0.000014808489,0.0008458172],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991689,0.0003526848,0.00007551289,0.00017022272,0.00015486676,0.00007784354],"domain_scores_gemma":[0.99945015,0.00011671924,0.00016391875,0.00006292304,0.00007410683,0.00013212785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010898935,0.00052743114,0.0009991132,0.00028627543,0.00025378447,0.00044752995,0.00029939704,0.0006334634,0.0024807232],"category_scores_gemma":[0.0015836813,0.00026905042,0.00043904324,0.00023071296,0.0004073892,0.00047747296,0.00029502998,0.0006605648,0.00054770475],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6607366,0.02433046,0.012856207,0.000574356,0.0009330305,0.00028872996,0.00032234492,0.00053289474,0.24081628,0.00014313808,0.0008084341,0.057657413],"study_design_scores_gemma":[0.028135,0.8335216,0.09235693,0.000034637065,0.0009869653,0.0005280764,0.00025562543,0.001863609,0.039200496,0.0001344596,0.0029197559,0.00006290214],"about_ca_topic_score_codex":0.00028558628,"about_ca_topic_score_gemma":0.00026163596,"teacher_disagreement_score":0.0024807232,"about_ca_system_score_codex":0.00020273028,"about_ca_system_score_gemma":0.00026379808,"threshold_uncertainty_score":0.008298814},"labels":[],"label_agreement":null},{"id":"W2000868686","doi":"10.5414/cp201687","title":"Single-dose, 2-way crossover, bioequivalence study of two rosuvastatin formulations in normal healthy subjects under fasting conditions","year":2012,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada); Pharmaxis (Canada)","funders":"","keywords":"Bioequivalence; Rosuvastatin; Pharmacokinetics; Medicine; Tolerability; Crossover study; Confidence interval; Pharmacology; Rosuvastatin Calcium; Adverse effect; Dosing; Internal medicine; Placebo","score_opus":0.1491367167304826,"score_gpt":0.49789304087878067,"score_spread":0.34875632414829805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000868686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963445,0.00044456703,0.0010975744,0.00006088783,0.00011105562,0.0012561893,0.00029667892,0.00005900595,0.00032948467],"genre_scores_gemma":[0.9919458,0.00036899914,0.0034284976,0.00021832473,0.00017297248,0.002133819,0.0004507154,0.000028858454,0.0012520506],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99717724,0.0013649833,0.00023814372,0.00059870636,0.0004081703,0.0002127962],"domain_scores_gemma":[0.9984724,0.0003271152,0.00038653857,0.00030495756,0.00020304906,0.00030600344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004341067,0.0013905871,0.0035902932,0.0006008513,0.000596654,0.0009176728,0.00065425155,0.0015921678,0.0029484623],"category_scores_gemma":[0.0032116247,0.0008762,0.0011908313,0.00045099022,0.0014177407,0.0011359839,0.00042465117,0.001542515,0.0008226544],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79029906,0.060062855,0.0029173514,0.0005483727,0.0009035569,0.000099905235,0.0005982718,0.0004888168,0.120181836,0.00016909192,0.000524947,0.023205869],"study_design_scores_gemma":[0.10393666,0.8540818,0.024941336,0.00002450698,0.00087415887,0.0001601174,0.00016871432,0.0015250655,0.012619627,0.00016528816,0.0014260905,0.0000765585],"about_ca_topic_score_codex":0.000495879,"about_ca_topic_score_gemma":0.00048604963,"teacher_disagreement_score":0.004341067,"about_ca_system_score_codex":0.00045170166,"about_ca_system_score_gemma":0.00078395254,"threshold_uncertainty_score":0.02295804},"labels":[],"label_agreement":null},{"id":"W2004522416","doi":"10.5414/cpp45307","title":"Assessment of the safety, tolerability, and PK/PD properties of two new formulations of subcutaneously administered IFN-?1a: a double-blind, placebo-controlled comparison with the currently available formulation","year":2007,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Medicine; Placebo; Discontinuation; Adverse effect; Pharmacokinetics; Pharmacodynamics; Visual analogue scale; Dosing; Anesthesia; Internal medicine","score_opus":0.12919494576900195,"score_gpt":0.47157832149799483,"score_spread":0.3423833757289929,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004522416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945674,0.002625068,0.0006325635,0.00009248239,0.00020990291,0.0011448408,0.0002318621,0.000034976176,0.00046097394],"genre_scores_gemma":[0.98869574,0.0023506905,0.0032751297,0.00025720173,0.00052131683,0.0025306225,0.0005095444,0.000020441079,0.001839326],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99921405,0.0003314388,0.000078642646,0.00015941571,0.00015325114,0.00006310515],"domain_scores_gemma":[0.9989662,0.00027273316,0.00041282302,0.00007687585,0.00008429323,0.00018694316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018446074,0.0010768125,0.0025128783,0.000471443,0.00029069054,0.0006184469,0.00087884767,0.0016246019,0.003107875],"category_scores_gemma":[0.0012047464,0.00056170544,0.0010871586,0.00029642702,0.0011216176,0.001081826,0.00027833358,0.001936196,0.0005163968],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8606341,0.049373083,0.0007965023,0.0009535489,0.00049109984,0.00005738878,0.000095344105,0.0003057291,0.05901861,0.00011853042,0.0002619435,0.027894147],"study_design_scores_gemma":[0.367461,0.61691445,0.003748722,0.00002911458,0.00046583684,0.00010322606,0.000031085554,0.0006086604,0.009877599,0.00005713218,0.0006726025,0.00003063331],"about_ca_topic_score_codex":0.0001945206,"about_ca_topic_score_gemma":0.00036906995,"teacher_disagreement_score":0.003107875,"about_ca_system_score_codex":0.00036453048,"about_ca_system_score_gemma":0.0005062729,"threshold_uncertainty_score":0.010396898},"labels":[],"label_agreement":null},{"id":"W2018115393","doi":"10.5414/cp201774","title":"Evaluation of the safety and efficacy of warfarin in Taiwanese patients","year":2013,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"","keywords":"Warfarin; Medicine; Incidence (geometry); Retrospective cohort study; Internal medicine; Anticoagulant; Surgery; Atrial fibrillation","score_opus":0.1590556497314907,"score_gpt":0.49935813288553105,"score_spread":0.3403024831540403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018115393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991886,0.00030239538,0.000049100814,0.000048333306,0.0000021432897,0.000005518208,0.00011144212,0.0000018315999,0.0002906444],"genre_scores_gemma":[0.9995733,0.000110040215,0.000059883198,0.000019561332,0.000008569879,0.0000048500324,0.00016413513,7.5794946e-7,0.000058835776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992256,0.0002435301,0.00019175478,0.00009265141,0.00017024002,0.000076167125],"domain_scores_gemma":[0.99627376,0.0004922587,0.0023690849,0.00016172118,0.0004245806,0.0002785068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011615924,0.00018741265,0.00027512063,0.00067977165,0.00023852215,0.00047660992,0.00018599702,0.00025830866,0.00087052624],"category_scores_gemma":[0.0040272665,0.00012549992,0.0003620407,0.0007683775,0.00019864619,0.00033596356,0.00026294735,0.00031032518,0.00017150807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015428616,0.000021543403,0.9981007,0.000010359285,0.000030628165,0.000078644225,0.000057960362,0.000021410351,0.00014119194,0.0000052190003,0.000029864845,0.0013482488],"study_design_scores_gemma":[0.000017550667,0.00041027777,0.9979888,0.000010918253,0.000039719664,0.0006583597,0.00016313087,0.00024146133,0.0002372809,0.000012662617,0.00021544838,0.000004409749],"about_ca_topic_score_codex":0.0017601404,"about_ca_topic_score_gemma":0.0016781107,"teacher_disagreement_score":0.0017601404,"about_ca_system_score_codex":0.0003377356,"about_ca_system_score_gemma":0.00036042766,"threshold_uncertainty_score":0.0061431527},"labels":[],"label_agreement":null},{"id":"W2038387558","doi":"10.5414/cpp43485","title":"The bioequivalence of highly variable drugs and drug products","year":2005,"lang":"en","type":"review","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Bioequivalence; Cmax; Confidence interval; Statistics; Mathematics; Replicate; Population; Pharmacology; Drug; Pharmacokinetics; Geometric mean; Medicine; Econometrics","score_opus":0.5790763290199263,"score_gpt":0.6584686201810384,"score_spread":0.07939229116111202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038387558","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.350581,0.021105299,0.5635883,0.002177286,0.0007216179,0.0024378123,0.0011199,0.0006027429,0.05766607],"genre_scores_gemma":[0.8913124,0.0043036356,0.09627952,0.00077727437,0.00015885025,0.0016019861,0.00050589594,0.00010806314,0.0049524317],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97103125,0.019180493,0.0015967397,0.0020935994,0.005598446,0.0004995185],"domain_scores_gemma":[0.98775965,0.00797275,0.0017721496,0.0015900058,0.00071927434,0.000186305],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020191064,0.00026257482,0.0011650422,0.0009088733,0.00034357177,0.0021199721,0.0009785896,0.0013388628,0.0032924898],"category_scores_gemma":[0.029278765,0.00025065092,0.0007443321,0.001346955,0.0023826791,0.0012654912,0.0012863961,0.0013702934,0.0007979243],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051495293,0.0008501943,0.012257676,0.0021226753,0.0005211935,0.0003621516,0.0015172319,0.01565395,0.09295855,0.13197538,0.0039140135,0.73271745],"study_design_scores_gemma":[0.0018775318,0.037997272,0.14536858,0.001373304,0.00084913854,0.0046134074,0.0010041397,0.09761304,0.17920275,0.23250854,0.2970833,0.00050902367],"about_ca_topic_score_codex":0.0005932658,"about_ca_topic_score_gemma":0.0003587332,"teacher_disagreement_score":0.9798089,"about_ca_system_score_codex":0.0011067226,"about_ca_system_score_gemma":0.0011252434,"threshold_uncertainty_score":0.10678178},"labels":[],"label_agreement":null},{"id":"W2046555511","doi":"10.5414/cpp48158","title":"Differences in bioavailability between 60 mg of nifedipine osmotic push-pull systems after fasted and fed administration","year":2010,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Oral and gingival health research","field":"Health Professions","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nifedipine; Bioavailability; Pharmacokinetics; Crossover study; Dosing; Medicine; Pharmacology; Chemistry; Animal science; Internal medicine; Calcium","score_opus":0.2433460164050536,"score_gpt":0.5888531536456633,"score_spread":0.34550713724060966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046555511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99886346,0.0004916802,0.0003772857,0.000012573048,0.000015576987,0.000034434303,0.00007792409,0.000014984928,0.0001120271],"genre_scores_gemma":[0.9967566,0.0006832374,0.0014358488,0.000037390204,0.00003253642,0.000081576945,0.00032932684,0.000016432818,0.0006269326],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.999433,0.00013855213,0.00004545951,0.000116615316,0.00019149392,0.00007486783],"domain_scores_gemma":[0.99949,0.0001495472,0.00015887912,0.000054105312,0.00006714584,0.00008024359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007478701,0.00031503808,0.0007816428,0.00025551338,0.00015842218,0.00044174574,0.00022779992,0.00036626103,0.0010421348],"category_scores_gemma":[0.0014275821,0.00021406953,0.00031469527,0.00018926282,0.00040972428,0.0005852732,0.00023361157,0.000613848,0.00017113677],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07110867,0.0018881737,0.0050659585,0.000284388,0.0002687293,0.00020062964,0.00029443463,0.00042451874,0.87726223,0.00011430344,0.0001722259,0.042915795],"study_design_scores_gemma":[0.0035784824,0.18707328,0.12809047,0.000041025916,0.00071927207,0.0010754656,0.00033216947,0.00435445,0.67151326,0.00012687856,0.0030126518,0.00008261643],"about_ca_topic_score_codex":0.0006004998,"about_ca_topic_score_gemma":0.00039139763,"teacher_disagreement_score":0.0010421348,"about_ca_system_score_codex":0.00030979898,"about_ca_system_score_gemma":0.00024696926,"threshold_uncertainty_score":0.0039551854},"labels":[],"label_agreement":null},{"id":"W2049111533","doi":"10.5414/cp201624","title":"A Phase I clinical trial of lodenafil carbonate, a new phosphodiesterase Type 5 (PDE5) inhibitor, in healthy male volunteers","year":2012,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Pharmacokinetics; Tolerability; Medicine; Adverse effect; Pharmacology; Prodrug; cGMP-specific phosphodiesterase type 5; Internal medicine; Erectile dysfunction","score_opus":0.21949713649752708,"score_gpt":0.5433063715469143,"score_spread":0.3238092350493872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049111533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228925,0.0017567789,0.0007842451,0.00023468169,0.00011121337,0.0031605514,0.0006131436,0.000069625225,0.0009804498],"genre_scores_gemma":[0.98774105,0.0014932981,0.0021859333,0.0007739072,0.00018462459,0.002733879,0.0013245415,0.000017990002,0.0035447753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997477,0.000086915745,0.00001409033,0.00006498344,0.000031013707,0.000055393884],"domain_scores_gemma":[0.9995541,0.000071804956,0.00008155764,0.000037584356,0.000041266572,0.00021381342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086538546,0.0012090149,0.0012653623,0.00026461174,0.00043193548,0.0004781949,0.0005659347,0.0011203918,0.0038747448],"category_scores_gemma":[0.00066225644,0.0004757831,0.0006106083,0.00021443378,0.00079550623,0.0005037685,0.0002525958,0.0019272666,0.0006633641],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.70335954,0.0905957,0.0030738781,0.0011154631,0.00060597877,0.0003399014,0.0002972971,0.0010181713,0.13817298,0.00015475879,0.0018402289,0.05942606],"study_design_scores_gemma":[0.2188599,0.7655516,0.0064562927,0.000021723994,0.00023534906,0.0001793584,0.00003664381,0.00037760386,0.0064903884,0.000059754522,0.0017120782,0.000019323563],"about_ca_topic_score_codex":0.00036529457,"about_ca_topic_score_gemma":0.0009844154,"teacher_disagreement_score":0.0038747448,"about_ca_system_score_codex":0.0002732987,"about_ca_system_score_gemma":0.000832246,"threshold_uncertainty_score":0.012962341},"labels":[],"label_agreement":null},{"id":"W2091561837","doi":"10.5414/cpp41153","title":"Comparison of the efficacy and tolerability of dexibuprofen and celecoxib in the treatment of osteoarthritis of the hip","year":2003,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Celecoxib; Tolerability; Ibuprofen; Osteoarthritis; Medicine; WOMAC; Adverse effect; Pharmacology; Internal medicine","score_opus":0.07967098357203387,"score_gpt":0.46717501980860576,"score_spread":0.3875040362365719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091561837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995158,0.003683519,0.0001567306,0.00009208692,0.0000738375,0.00027988708,0.00009506056,0.000009766802,0.00045118507],"genre_scores_gemma":[0.9970162,0.001567079,0.00036033947,0.000120324454,0.00021235643,0.00022006607,0.00018263963,0.0000029472958,0.00031801834],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987185,0.00082382123,0.00013007766,0.00010581071,0.00014015449,0.000081634986],"domain_scores_gemma":[0.9981128,0.000747442,0.0005730577,0.00009175842,0.00009392886,0.00038108946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001718073,0.0006193441,0.001477376,0.00043067182,0.00020698516,0.0005092934,0.00048263275,0.0008126263,0.0022388613],"category_scores_gemma":[0.002915061,0.00033411037,0.0009361602,0.0003121283,0.00070729444,0.0005160457,0.00024638948,0.0010734709,0.00027058207],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92635095,0.014422836,0.0032876334,0.00079434604,0.0009357935,0.00007544391,0.00008633493,0.00031415035,0.0104699265,0.000066881934,0.00017046063,0.04302527],"study_design_scores_gemma":[0.315068,0.6632648,0.01586342,0.0000508467,0.000889527,0.00015598847,0.00006018832,0.0005518347,0.0034498866,0.00007784863,0.00054770976,0.000019887639],"about_ca_topic_score_codex":0.00025648822,"about_ca_topic_score_gemma":0.0005059714,"teacher_disagreement_score":0.0022388613,"about_ca_system_score_codex":0.00033747716,"about_ca_system_score_gemma":0.00049169536,"threshold_uncertainty_score":0.009086132},"labels":[],"label_agreement":null},{"id":"W2313338238","doi":"10.5414/cpp42342","title":"A comparative clarithromycin bioavailability study: determination of clarithromycin and 14-(R)-hydroxyclarithromycin under fasting and fed conditions","year":2004,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Bioequivalence; Clarithromycin; Bioavailability; Cmax; Crossover study; Confidence interval; Pharmacology; Chromatography; Analyte; Medicine; Chemistry; Internal medicine","score_opus":0.11430816614270914,"score_gpt":0.48902211348266283,"score_spread":0.37471394733995367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313338238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976405,0.00059442123,0.0008892749,0.000023512324,0.000025428972,0.00028973148,0.00018179255,0.00003114381,0.00032416714],"genre_scores_gemma":[0.9936213,0.0003773179,0.0038602399,0.00012462515,0.000057610232,0.00034364738,0.00061176316,0.000019732746,0.0009837961],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9984243,0.0005881769,0.00009395163,0.0004293917,0.0003945674,0.00006973102],"domain_scores_gemma":[0.99843353,0.0003019272,0.00041105703,0.00030462042,0.00023296729,0.0003159113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019107278,0.00073539553,0.0015931309,0.00029168554,0.00044274106,0.00057133206,0.0005377944,0.0013237686,0.0019098006],"category_scores_gemma":[0.002729009,0.00044853234,0.00052808534,0.00032943868,0.0009575361,0.0006780619,0.00032288686,0.0008478396,0.00029952722],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.21234767,0.011089278,0.006083468,0.00043902005,0.000459957,0.00013427588,0.00039608026,0.00044589493,0.73078597,0.00010519191,0.00037313194,0.037340067],"study_design_scores_gemma":[0.015707226,0.6600955,0.13457464,0.000037567974,0.0009487799,0.0012412174,0.00018813407,0.002437869,0.18185651,0.0000952333,0.002694583,0.00012272582],"about_ca_topic_score_codex":0.0014342163,"about_ca_topic_score_gemma":0.0015691663,"teacher_disagreement_score":0.0019107278,"about_ca_system_score_codex":0.00062898116,"about_ca_system_score_gemma":0.00070479646,"threshold_uncertainty_score":0.010105014},"labels":[],"label_agreement":null},{"id":"W2314401326","doi":"10.5414/cpp44180","title":"Comparative bioavailability of a generic capsule formulation of the reverse transcriptase inhibitor efavirenz and the innovator product","year":2006,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BioPhage Pharma (Canada)","funders":"","keywords":"Efavirenz; Bioequivalence; Reverse-transcriptase inhibitor; Pharmacokinetics; Capsule; Bioavailability; Cmax; Pharmacology; Crossover study; Medicine; Chemistry; Human immunodeficiency virus (HIV); Viral load; Virology; Biology; Antiretroviral therapy; Placebo","score_opus":0.06567932079286021,"score_gpt":0.4078633520262846,"score_spread":0.3421840312334244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314401326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979519,0.0008930115,0.0005159657,0.000028197072,0.000026888954,0.00007115205,0.00013687568,0.000011612838,0.0003643657],"genre_scores_gemma":[0.99739623,0.00041023034,0.0011333473,0.00005240232,0.0000394138,0.000069929854,0.00040426702,0.00000942379,0.0004848845],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99897146,0.0004333428,0.000066948254,0.00022283357,0.00023844527,0.00006703016],"domain_scores_gemma":[0.9992066,0.00024684318,0.000285728,0.00007802813,0.00008815477,0.000094618656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016362742,0.00029620805,0.0006937363,0.00024529884,0.00012335763,0.00047777093,0.00026382602,0.00047919105,0.0025104508],"category_scores_gemma":[0.0020264816,0.00019498986,0.00044829465,0.00022103607,0.00033453587,0.00047942062,0.00022078627,0.0005049788,0.0002686731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3314183,0.008391883,0.022311231,0.0010999849,0.0010619296,0.0004084494,0.0006606609,0.0012003084,0.49132833,0.0005868345,0.0010075542,0.14052449],"study_design_scores_gemma":[0.021391997,0.69583327,0.14953926,0.00009304849,0.0016739619,0.0019247964,0.00036894198,0.0054235463,0.1166844,0.0002249628,0.0067244847,0.000117423355],"about_ca_topic_score_codex":0.0003320644,"about_ca_topic_score_gemma":0.0001781279,"teacher_disagreement_score":0.0025104508,"about_ca_system_score_codex":0.00029470443,"about_ca_system_score_gemma":0.00023901592,"threshold_uncertainty_score":0.008653581},"labels":[],"label_agreement":null},{"id":"W2315156665","doi":"10.5414/cp201603","title":"Once daily nifedipine: the formulation dictates the pharmacokinetic characteristics and the therapeutic responses","year":2012,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Nifedipine; Medicine; Pharmacokinetics; Angina; Pharmacology; Clinical trial; Regimen; Bioequivalence; Internal medicine","score_opus":0.0635210436057631,"score_gpt":0.43724859029219487,"score_spread":0.37372754668643177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315156665","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021938147,0.9619767,0.0025446317,0.0029312884,0.00052408286,0.00018107482,0.0009951455,0.000039197166,0.008869788],"genre_scores_gemma":[0.16583267,0.8137627,0.009729376,0.0032084477,0.0015470093,0.00032480856,0.0011080487,0.00006050312,0.0044264207],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99850696,0.00044549158,0.00033659997,0.00016667518,0.00049891573,0.000045389243],"domain_scores_gemma":[0.9973646,0.0016196652,0.0005552744,0.00006104487,0.00036790548,0.00003159735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023777108,0.00020978626,0.0010801249,0.0012604563,0.00017716612,0.0016252409,0.0003956246,0.0010399627,0.0039918763],"category_scores_gemma":[0.0053400686,0.00016073484,0.0007689837,0.0015357857,0.00035951516,0.0016356393,0.00024577384,0.00065962377,0.0010296308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016302391,0.00016995257,0.002789465,0.07571807,0.0007225778,0.00075344724,0.00029500943,0.00023733063,0.03768408,0.003449113,0.011248483,0.8653022],"study_design_scores_gemma":[0.0011128447,0.003957376,0.044378567,0.051692035,0.0074322363,0.010875039,0.0011085728,0.00086543465,0.056276955,0.009344556,0.8127198,0.00023657977],"about_ca_topic_score_codex":0.0010154273,"about_ca_topic_score_gemma":0.001615346,"teacher_disagreement_score":0.0039918763,"about_ca_system_score_codex":0.0007137205,"about_ca_system_score_gemma":0.0010240274,"threshold_uncertainty_score":0.013354123},"labels":[],"label_agreement":null},{"id":"W2317924448","doi":"10.5414/cp201546","title":"Safety, tolerability, and pharmacokinetics of once-daily trazodone extended-release caplets in healthy subjects","year":2011,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Treatment of Major Depression","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Pharmacokinetics; Trazodone; Tolerability; Bioavailability; Ingestion; Oral administration; Pharmacology; Area under the curve; Medicine; Meal; Internal medicine; Adverse effect; Antidepressant","score_opus":0.10571511399713195,"score_gpt":0.4513624411461794,"score_spread":0.34564732714904745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317924448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974366,0.0014025988,0.00032415063,0.000019852845,0.000012093377,0.00012940633,0.00019821565,0.000027411641,0.00044968893],"genre_scores_gemma":[0.9978314,0.0005912436,0.00048348997,0.000102035396,0.000036302332,0.000089167865,0.00032770337,0.000006898258,0.0005316732],"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99966884,0.00012043709,0.000020516749,0.00007676019,0.00008673336,0.000026772464],"domain_scores_gemma":[0.9995018,0.00013511835,0.00015702174,0.000039823455,0.000072304254,0.000093831644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006755386,0.00048810832,0.0006543947,0.00021784643,0.0002616417,0.00035917843,0.00019009152,0.0005174448,0.0010788481],"category_scores_gemma":[0.0008667223,0.00020052923,0.00024652554,0.0001707625,0.00029530996,0.00023827371,0.000092218565,0.0004793244,0.000360014],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.19738425,0.019061469,0.1831023,0.0015117071,0.0009060007,0.0030210798,0.0011760001,0.0012248016,0.37597144,0.00015175948,0.0018472157,0.21464199],"study_design_scores_gemma":[0.00543442,0.30929786,0.6541745,0.00006308665,0.00055004563,0.0030810584,0.00028034768,0.002508977,0.021646619,0.000059194834,0.002840134,0.000063680054],"about_ca_topic_score_codex":0.0011004359,"about_ca_topic_score_gemma":0.0008498524,"teacher_disagreement_score":0.0011004359,"about_ca_system_score_codex":0.0002437164,"about_ca_system_score_gemma":0.0002502495,"threshold_uncertainty_score":0.0036091208},"labels":[],"label_agreement":null},{"id":"W2320209167","doi":"10.5414/cpp39162","title":"Evaluation of some properties of individual bioequivalence (IBE) from replicate-design studies","year":2001,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Bioequivalence; Replicate; Econometrics; Aggregate (composite); Crossover; Cmax; Statistics; Variance (accounting); Set (abstract data type); Mathematics; Computer science; Economics; Bioavailability; Biology; Pharmacology; Machine learning","score_opus":0.8995036027209984,"score_gpt":0.691613292949327,"score_spread":0.20789030977167133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320209167","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34372172,0.0049518156,0.6386231,0.0006223725,0.00012555346,0.0017931107,0.0014501188,0.00048629838,0.00822587],"genre_scores_gemma":[0.90724957,0.00045826813,0.08914542,0.0002287667,0.00012943626,0.0013716504,0.0009598217,0.00012060207,0.0003365123],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.81529653,0.13518693,0.011189349,0.011241035,0.026062185,0.0010238863],"domain_scores_gemma":[0.22569762,0.6695956,0.049779005,0.044507794,0.009301402,0.0011185342],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.26060224,0.0012968489,0.0030287376,0.004278436,0.00069274567,0.0024553183,0.0023780738,0.0027815097,0.0031253162],"category_scores_gemma":[0.4552179,0.0007888896,0.005732173,0.003126862,0.002966471,0.0043846862,0.002364462,0.0026238956,0.0004385616],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018055372,0.0015179636,0.25354847,0.0070965444,0.02006445,0.0010736196,0.0028021284,0.2237341,0.010966888,0.041507024,0.0030192186,0.41661426],"study_design_scores_gemma":[0.0012743811,0.030019954,0.24145614,0.0010898868,0.008320544,0.0040545985,0.0005779067,0.54428905,0.022538835,0.12905698,0.016755244,0.0005664712],"about_ca_topic_score_codex":0.0002664954,"about_ca_topic_score_gemma":0.0001894246,"teacher_disagreement_score":0.73939776,"about_ca_system_score_codex":0.00156449,"about_ca_system_score_gemma":0.0011633786,"threshold_uncertainty_score":0.9118091},"labels":[],"label_agreement":null},{"id":"W2323818785","doi":"10.5414/cpp41217","title":"Scaling or wider bioequivalence limits for highly variable drugs and for the special case of Cmax","year":2003,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Toronto","funders":"","keywords":"Bioequivalence; Cmax; Geometric mean; Statistics; Scaling; Mathematics; Metric (unit); Drug; Econometrics; Pharmacology; Medicine; Pharmacokinetics","score_opus":0.6098432465095782,"score_gpt":0.6446210051782783,"score_spread":0.03477775866870003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323818785","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7519015,0.0016616395,0.24013832,0.00031878645,0.000054122876,0.00042505024,0.00015667624,0.00019970779,0.005144185],"genre_scores_gemma":[0.9437833,0.00020546092,0.055375718,0.00008191891,0.00002002186,0.00025324215,0.00006851809,0.000014212919,0.00019756271],"study_design_codex":"simulation_or_modeling","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9953805,0.0029997947,0.00021662458,0.0006327819,0.0006687472,0.000101485464],"domain_scores_gemma":[0.9832829,0.012530783,0.0020718952,0.0015420932,0.0004566107,0.00011567222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073034624,0.0006562005,0.001002215,0.00033043456,0.00020508569,0.0007928099,0.0006260719,0.0008642314,0.001475546],"category_scores_gemma":[0.022393182,0.00023272277,0.00094788725,0.0003336555,0.00089019455,0.00079759397,0.00062046456,0.0009102967,0.00011050954],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063201566,0.0011100337,0.050304387,0.0025076119,0.0009661465,0.0014104523,0.00085954403,0.41760647,0.28654143,0.030942174,0.001281194,0.20015046],"study_design_scores_gemma":[0.00077098876,0.02878968,0.10078687,0.00043678572,0.0010268195,0.0034729382,0.0003009002,0.6424938,0.16861296,0.0362861,0.016704248,0.0003179898],"about_ca_topic_score_codex":0.00024372849,"about_ca_topic_score_gemma":0.00019919244,"teacher_disagreement_score":0.0073034624,"about_ca_system_score_codex":0.00035646293,"about_ca_system_score_gemma":0.0005224962,"threshold_uncertainty_score":0.038624883},"labels":[],"label_agreement":null},{"id":"W2327248072","doi":"10.5414/cpp48400","title":"Therapeutically relevant blood pressure differences with two nifedipine (60 mg) osmotic delivery systems of differing design: three case reports","year":2010,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Nifedipine; Blood pressure; Medicine; Bioequivalence; Pharmacology; Anesthesia; Pharmacokinetics; Internal medicine; Calcium","score_opus":0.06302953436985198,"score_gpt":0.3879503145838778,"score_spread":0.3249207802140258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327248072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96378195,0.006336657,0.01172517,0.0045596263,0.00068349694,0.00045648668,0.00014226638,0.00032738698,0.011987054],"genre_scores_gemma":[0.989617,0.0013954103,0.004576435,0.0016186564,0.0007927462,0.00009044372,0.00007054324,0.00005764814,0.0017811268],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9950813,0.0009091914,0.00084557495,0.0007567609,0.001187842,0.0012192925],"domain_scores_gemma":[0.99069744,0.0040655727,0.0025412536,0.00075921265,0.0003696164,0.001566753],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002203371,0.0044117635,0.0015935336,0.0032074172,0.0035489881,0.0037031674,0.0029972985,0.013382086,0.0013909605],"category_scores_gemma":[0.014492201,0.0024327554,0.003766725,0.0025659024,0.0045594303,0.0029823198,0.0023771713,0.008204469,0.0009183279],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010106983,0.00015821254,0.004160471,0.00005170059,0.000031870346,0.99144953,0.00053355534,0.0001253594,0.00078735524,0.00045433413,0.00019264007,0.0019539113],"study_design_scores_gemma":[0.000028733139,0.00016261722,0.0014548511,0.000013618043,0.00002816229,0.9958811,0.00017346538,0.00030832758,0.0012383221,0.00010796121,0.0005832909,0.0000196135],"about_ca_topic_score_codex":0.0030732418,"about_ca_topic_score_gemma":0.0032137933,"teacher_disagreement_score":0.013382086,"about_ca_system_score_codex":0.003420545,"about_ca_system_score_gemma":0.0009895543,"threshold_uncertainty_score":0.024817944},"labels":[],"label_agreement":null},{"id":"W2333417510","doi":"10.5414/cpp38563","title":"Independent determinants of the efficacy of nitrate therapy","year":2000,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Nitric Oxide and Endothelin Effects","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Angina; Internal medicine; Quality of life (healthcare); Concomitant; Diabetes mellitus; Coronary artery disease; Canadian Cardiovascular Society; Isosorbide dinitrate; Cardiology; Physical therapy; Myocardial infarction; Endocrinology","score_opus":0.07171186489163403,"score_gpt":0.45777791838415327,"score_spread":0.3860660534925192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333417510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976816,0.0006825905,0.00022427141,0.00016252234,0.000014755247,0.0000115088915,0.00019039713,0.0000054629104,0.0010268139],"genre_scores_gemma":[0.99952734,0.00008450079,0.00011044444,0.000018589924,0.000029917603,0.0000061829614,0.00012838932,0.0000024246283,0.00009232221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919254,0.00033349986,0.000093586204,0.00011277545,0.00018684006,0.000080665886],"domain_scores_gemma":[0.9882712,0.0071666245,0.0025978282,0.00031034,0.00053811696,0.0011158823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010266164,0.00024767997,0.00031216134,0.00028568457,0.00013444296,0.00036946495,0.00024507908,0.00048023774,0.003217871],"category_scores_gemma":[0.007814883,0.00009877986,0.00048225265,0.0002986259,0.00029365686,0.00017081236,0.00017921174,0.0008709211,0.00029942472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008674934,0.00013643772,0.99488884,0.00001891729,0.0001884195,0.0000654405,0.000016796848,0.00018025504,0.00042848123,0.00003154435,0.00009200759,0.0030853504],"study_design_scores_gemma":[0.000032325584,0.00029524698,0.99832445,0.000007782275,0.00010741429,0.00018875794,0.000016351714,0.00070880796,0.0001402948,0.000054906814,0.00012014283,0.0000035265532],"about_ca_topic_score_codex":0.00043986013,"about_ca_topic_score_gemma":0.00052960566,"teacher_disagreement_score":0.003217871,"about_ca_system_score_codex":0.0001915058,"about_ca_system_score_gemma":0.00033169895,"threshold_uncertainty_score":0.010764897},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2333953760","doi":"10.5414/cpp38061","title":"Interethnic differences of drug-metabolizing enzymes","year":2000,"lang":"en","type":"review","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmacogenetics and Drug Metabolism","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","keywords":"Pharmacogenetics; Biology; Ethnic group; Population; Genetics; Allele; Genotype; Phenotype; Drug; Population genetics; Evolutionary biology; Gene; Pharmacology; Medicine; Environmental health","score_opus":0.37425123815277705,"score_gpt":0.5991028266829549,"score_spread":0.22485158853017784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333953760","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868406,0.003936077,0.0014551234,0.00016756299,0.000042313906,0.000011399674,0.0005842803,0.000015673908,0.006946853],"genre_scores_gemma":[0.99766904,0.00087284984,0.00033363857,0.000040261286,0.000014540317,0.0000057536845,0.00028665244,0.000008659052,0.0007684778],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995303,0.00012779712,0.000062389816,0.00013607966,0.0000861381,0.000057188263],"domain_scores_gemma":[0.9993173,0.00017985923,0.00020862445,0.00009644034,0.00012234783,0.00007551691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004885533,0.00011440655,0.00025938218,0.0003740512,0.00026594056,0.00052418275,0.00013164709,0.00016474185,0.0021209356],"category_scores_gemma":[0.0013273932,0.00008185209,0.0002217208,0.0007194949,0.0001629033,0.00018961595,0.00027605655,0.00023978333,0.00034830908],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006390257,0.00010643817,0.9039592,0.0001147709,0.00074300397,0.00063898356,0.0017542053,0.00014926154,0.041066222,0.001957652,0.0006613067,0.048209827],"study_design_scores_gemma":[0.0000033542779,0.00007291547,0.9939314,0.000009802025,0.00009297294,0.0005471468,0.000254191,0.0001229206,0.0016277782,0.00030353185,0.0030275763,0.000006451121],"about_ca_topic_score_codex":0.0020132766,"about_ca_topic_score_gemma":0.002307426,"teacher_disagreement_score":0.0021209356,"about_ca_system_score_codex":0.00012303481,"about_ca_system_score_gemma":0.00012009879,"threshold_uncertainty_score":0.0070952773},"labels":[],"label_agreement":null},{"id":"W2769816741","doi":"10.5414/cp203151","title":"Global perspectives on ensuring the safety of pharmaceutical products in the distribution process","year":2017,"lang":"en","type":"article","venue":"International Journal of Clinical Pharmacology and Therapeutics","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Distribution (mathematics); Standardization; European union; Good manufacturing practice; Counterfeit; Business; Cold chain; Public health; Best practice; Medicine; Marketing; International trade; Supply chain; Political science; Engineering; Law","score_opus":0.17863396735093146,"score_gpt":0.5529613400693532,"score_spread":0.3743273727184217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769816741","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.022103323,0.16946371,0.037397794,0.6469624,0.005382285,0.00018802959,0.00041992601,0.00031242074,0.1177701],"genre_scores_gemma":[0.5414621,0.1931988,0.06571638,0.17074507,0.005456765,0.0003402579,0.0009446854,0.00021290603,0.02192312],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.96994364,0.016577668,0.0015549493,0.0016972664,0.008297494,0.0019290429],"domain_scores_gemma":[0.93784404,0.024962192,0.009223051,0.0053439434,0.01900162,0.0036251568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0390673,0.00085521635,0.00070811016,0.002259742,0.0023421694,0.01280012,0.0015300784,0.006670135,0.008660125],"category_scores_gemma":[0.028476093,0.00030530352,0.0009266982,0.003313747,0.011412845,0.010965606,0.0053301724,0.0067590475,0.0013585925],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002175961,0.00032130172,0.012582531,0.004334017,0.00013173338,0.0006631135,0.0071314466,0.0021795512,0.0038637463,0.46274626,0.08159665,0.424232],"study_design_scores_gemma":[0.0000405182,0.00035002918,0.01453528,0.006127777,0.00011433529,0.0008425818,0.008649143,0.00077637815,0.002616995,0.17359084,0.7922662,0.00008989956],"about_ca_topic_score_codex":0.005205221,"about_ca_topic_score_gemma":0.0031317915,"teacher_disagreement_score":0.0390673,"about_ca_system_score_codex":0.0052641346,"about_ca_system_score_gemma":0.020913355,"threshold_uncertainty_score":0.20661008},"labels":[],"label_agreement":null}]}